Galectin-3 is a protein that in humans is encoded by the LGALS3 gene. Galectin-3 is a member of the lectin family, of which 14 mammalian galectins have been identified.?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Galectin 3 industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
GAL-300
GRMD-03
ANG-4021
KTI
Others
Market Segment by Product Application
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Galectin 3 consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Galectin 3 market by identifying its various subsegments.
3.Focuses on the key global Galectin 3 manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Galectin 3 with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Galectin 3 submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Galectin 3 Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Galectin 3 Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Galectin 3 Segment by Type
2.1.1 GAL-300
2.1.2 GRMD-03
2.1.3 ANG-4021
2.1.4 KTI
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Liver Cirrhosis
2.2.2 Portal Hypertension
2.2.3 Metastatic Melanoma
2.2.4 Others
2.3 Global Galectin 3 Market Comparison by Regions (2017-2027)
2.3.1 Global Galectin 3 Market Size (2017-2027)
2.3.2 North America Galectin 3 Status and Prospect (2017-2027)
2.3.3 Europe Galectin 3 Status and Prospect (2017-2027)
2.3.4 China Galectin 3 Status and Prospect (2017-2027)
2.3.5 Japan Galectin 3 Status and Prospect (2017-2027)
2.3.6 Southeast Asia Galectin 3 Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Galectin 3 Industry Impact
2.5.1 Galectin 3 Business Impact Assessment - Covid-19
2.5.2 Market Trends and Galectin 3 Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Galectin 3 Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Galectin 3 Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Galectin 3 Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Galectin 3 Manufacturer Market Share
3.5 Top 10 Galectin 3 Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Galectin 3 Market
3.7 Key Manufacturers Galectin 3 Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Galectin 3 Industry Key Manufacturers
4.1 Angion Biomedica Corp
4.1.1 Compan Detail
4.1.2 Angion Biomedica Corp Galectin 3 Product Introduction, Application and Specification
4.1.3 Angion Biomedica Corp 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Angion Biomedica Corp News
4.2 Bristol-Myers Squibb Company
4.2.1 Compan Detail
4.2.2 Bristol-Myers Squibb Company Galectin 3 Product Introduction, Application and Specification
4.2.3 Bristol-Myers Squibb Company Galectin 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Angion Biomedica Corp News
4.3 Galectin Therapeutics Inc
4.3.1 Compan Detail
4.3.2 Galectin Therapeutics Inc Galectin 3 Product Introduction, Application and Specification
4.3.3 Galectin Therapeutics Inc Galectin 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Galectin Therapeutics Inc News
4.4 GlycoMimetics Inc
4.4.1 Compan Detail
4.4.2 GlycoMimetics Inc Galectin 3 Product Introduction, Application and Specification
4.4.3 GlycoMimetics Inc Galectin 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 GlycoMimetics Inc News
4.5 iTeos Therapeutics SA
4.5.1 Compan Detail
4.5.2 GlycoMimetics Inc Galectin 3 Product Introduction, Application and Specification
4.5.3 iTeos Therapeutics SA Galectin 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 iTeos Therapeutics SA News
4.6 MandalMed Inc
4.6.1 Compan Detail
4.6.2 MandalMed Inc Galectin 3 Product Introduction, Application and Specification
4.6.3 MandalMed Inc Galectin 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 MandalMed Inc News
5 Global Galectin 3 Market Segment by Big Type
5.1 Global Galectin 3 Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Galectin 3 Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Galectin 3 Revenue and Market Share by Big Type (2017-2022)
5.2 GAL-300 Sales Growth Rate and Price
5.2.1 Global GAL-300 Sales Growth Rate (2017-2022)
5.2.2 Global GAL-300 Price (2017-2022)
5.3 GRMD-03 Sales Growth Rate and Price
5.3.1 Global GRMD-03 Sales Growth Rate (2017-2022)
5.3.2 Global GRMD-03 Price (2017-2022)
5.4 ANG-4021 Sales Growth Rate and Price
5.4.1 Global ANG-4021 Sales Growth Rate (2017-2022)
5.4.2 Global ANG-4021 Price (2017-2022)
5.5 KTI Sales Growth Rate and Price
5.5.1 Global KTI Sales Growth Rate (2017-2022)
5.5.2 Global KTI Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Galectin 3 Market Segment by Big Application
6.1 Global Galectin 3 Sales Market Share by Big Application (2017-2022)
6.2 Liver Cirrhosis Sales Growth Rate (2017-2022)
6.3 Portal Hypertension Sales Growth Rate (2017-2022)
6.4 Metastatic Melanoma Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Galectin 3 Forecast
7.1 Global Galectin 3 Revenue, Sales and Growth Rate (2022-2027)
7.2 Galectin 3 Market Forecast by Regions (2022-2027)
7.2.1 North America Galectin 3 Market Forecast (2022-2027)
7.2.2 Europe Galectin 3 Market Forecast (2022-2027)
7.2.3 China Galectin 3 Market Forecast (2022-2027)
7.2.4 Japan Galectin 3 Market Forecast (2022-2027)
7.2.5 Southeast Asia Galectin 3 Market Forecast (2022-2027)
7.2.6 Other Regions Galectin 3 Market Forecast (2022-2027)
7.3 Galectin 3 Market Forecast by Type (2022-2027)
7.3.1 Global Galectin 3 Sales Forecast by Type (2022-2027)
7.3.2 Global Galectin 3 Market Share Forecast by Type (2022-2027)
7.4 Galectin 3 Market Forecast by Application (2022-2027)
7.4.1 Global Galectin 3 Sales Forecast by Application (2022-2027)
7.4.2 Global Galectin 3 Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Galectin 3 Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Galectin 3 Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Galectin 3
Figure Market Concentration Ratio and Market Maturity Analysis of Galectin 3
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Galectin 3 Market Size by Big Type
Figure Global Market Share of Galectin 3 by Big Type in 2021
Figure GAL-300 Picture (2017-2022)
Figure GRMD-03 Picture (2017-2022)
Figure ANG-4021 Picture (2017-2022)
Figure KTI Picture (2017-2022)
Global Galectin 3 Market Size by Big Application
Table Global Galectin 3 Market Size by Application
Figure Global Galectin 3 Market Share by Big Application in 2021
Figure Liver Cirrhosis Picture
Figure Portal Hypertension Picture
Figure Metastatic Melanoma Picture
Figure Others Picture
Table Global Galectin 3 Comparison by Regions (M USD) (2017-2027)
Figure Global Galectin 3 Market Size (Million US$) (2017-2027)
Figure North America Galectin 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Galectin 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure China Galectin 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Galectin 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Galectin 3 Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Galectin 3 Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Galectin 3 Sales by Manufacturer (2017-2022)
Figure Global Galectin 3 Sales Market Share by Manufacturer in 2021
Table Global Galectin 3 Revenue by Manufacturer (2017-2022)
Figure Global Galectin 3 Revenue Market Share by Manufacturer in 2021
Table Global Galectin 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Galectin 3 Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Galectin 3 Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Galectin 3 Market
Table Key Manufacturers Galectin 3 Product Type
Table Mergers & Acquisitions Planning
Table Angion Biomedica Corp Company Profile
Table Galectin 3 Product Introduction, Application and Specification of Angion Biomedica Corp
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bristol-Myers Squibb Company Company Profile
Table Galectin 3 Product Introduction, Application and Specification of Bristol-Myers Squibb Company
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Company Recent Development
Table Galectin Therapeutics Inc Company Profile
Table Galectin 3 Product Introduction, Application and Specification of Galectin Therapeutics Inc
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Galectin Therapeutics Inc Main Business
Table Galectin Therapeutics Inc Recent Development
Table GlycoMimetics Inc Company Profile
Table Galectin 3 Product Introduction, Application and Specification of GlycoMimetics Inc
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlycoMimetics Inc Main Business
Table GlycoMimetics Inc Recent Development
Table GlycoMimetics Inc Main Business
Table GlycoMimetics Inc Recent Development
Table iTeos Therapeutics SA Company Profile
Table Galectin 3 Product Introduction, Application and Specification of iTeos Therapeutics SA
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table iTeos Therapeutics SA Main Business
Table iTeos Therapeutics SA Recent Development
Table MandalMed Inc Company Profile
Table Galectin 3 Product Introduction, Application and Specification of MandalMed Inc
Table Galectin 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MandalMed Inc Main Business
Table MandalMed Inc Recent Development
Figure Global Galectin 3 Sales and Growth Rate (2017-2022)
Figure Global Galectin 3 Revenue and Growth Rate (2017-2022)
Table Global Galectin 3 Sales by Regions (2017-2022)
Figure Global Galectin 3 Sales Market Share by Regions in 2021
Table Global Galectin 3 Revenue by Regions (2017-2022)
Figure Global Galectin 3 Revenue Market Share by Regions in 2021
Figure North America Galectin 3 Sales and Growth Rate (2017-2022)
Figure Europe Galectin 3 Sales and Growth Rate (2017-2022)
Figure China Galectin 3 Sales and Growth Rate (2017-2022)
Figure Japan Galectin 3 Sales and Growth Rate (2017-2022)
Figure Southeast Asia Galectin 3 Sales and Growth Rate (2017-2022)
Figure Other Regions Galectin 3 Sales and Growth Rate (2017-2022)
Table Global Galectin 3 Sales by Big Type (2017-2022)
Table Global Galectin 3 Sales Market Share by Big Type (2017-2022)
Figure Global Galectin 3 Sales Market Share by Big Type in 2019
Table Global Galectin 3 Revenue by Big Type (2017-2022)
Table Global Galectin 3 Revenue Market Share by Big Type (2017-2022)
Table Global Galectin 3 Revenue Market Share by Big Type in 2019
Figure Global GAL-300 Sales Growth Rate (2017-2022)
Figure Global GAL-300 Price (2017-2022)
Figure Global GRMD-03 Sales Growth Rate (2017-2022)
Figure Global GRMD-03 Price (2017-2022)
Figure Global ANG-4021 Sales Growth Rate (2017-2022)
Figure Global ANG-4021 Price (2017-2022)
Figure Global KTI Sales Growth Rate (2017-2022)
Figure Global KTI Price (2017-2022)
Table Global Galectin 3 Sales by Big Application (2017-2022)
Table Global Galectin 3 Sales Market Share by Big Application (2017-2022)
Figure Global Galectin 3 Sales Market Share by Big Application in 2019
Figure Global Liver Cirrhosis Sales Growth Rate (2017-2022)
Figure Global Portal Hypertension Sales Growth Rate (2017-2022)
Figure Global Metastatic Melanoma Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Galectin 3 Sales and Growth Rate (2022-2027)
Figure Global Galectin 3 Revenue and Growth Rate (2022-2027)
Table Global Galectin 3 Sales Forecast by Regions (2022-2027)
Table Global Galectin 3 Market Share Forecast by Regions (2022-2027)
Figure North America Sales Galectin 3 Market Forecast (2022-2027)
Figure Europe Sales Galectin 3 Market Forecast (2022-2027)
Figure China Sales Galectin 3 Market Forecast (2022-2027)
Figure Japan Sales Galectin 3 Market Forecast (2022-2027)
Figure Southeast Asia Sales Galectin 3 Market Forecast (2022-2027)
Figure Other Regions Sales Galectin 3 Market Forecast (2022-2027)
Table Global Galectin 3 Sales Forecast by Type (2022-2027)
Table Global Galectin 3 Market Share Forecast by Type (2022-2027)
Table Global Galectin 3 Sales Forecast by Application (2022-2027)
Table Global Galectin 3 Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Galectin 3
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Galectin 3 Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Galectin 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Galectin 3 Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Galectin 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Galectin 3 Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Galectin 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Galectin 3 Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Galectin 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc